Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Open Access
- 1 January 2023
- journal article
- review article
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. ume 15, 17-38
Abstract
After a detailed description of orexins and their roles in sleep and other medical disorders, we discuss here the current clinical evidence on the effects of dual (DORAs) or selective (SORAs) orexin receptor antagonists on insomnia with the aim to provide recommendations for their further assessment in a context of personalized and precision medicine. In the last decade, many trials have been conducted with orexin receptor antagonists, which represent an innovative and valid therapeutic option based on the multiple mechanisms of action of orexins on different biological circuits, both centrally and peripherally, and their role in a wide range of medical conditions which are often associated with insomnia. A very interesting aspect of this new category of drugs is that they have limited abuse liability and their discontinuation does not seem associated with significant rebound effects. Further studies on the efficacy of DORAs are required, especially on children and adolescents and in particular conditions, such as menopause. Which DORA is most suitable for each patient, based on comorbidities and/or concomitant treatments, should be the focus of further careful research. On the contrary, studies on SORAs, some of which seem to be appropriate also in insomnia in patients with psychiatric diseases, are still at an early stage and, therefore, do not allow to draw definite conclusions.Keywords
This publication has 234 references indexed in Scilit:
- Role of orexin in modulating arousal, feeding, and motivationFrontiers in Behavioral Neuroscience, 2013
- Mechanism for Hypocretin-mediated sleep-to-wake transitionsProceedings of the National Academy of Sciences, 2012
- Optogenetic Probing of Fast Glutamatergic Transmission from Hypocretin/Orexin to Histamine NeuronsIn SituJournal of Neuroscience, 2012
- Abnormal Sleep-Cardiovascular System Interaction in Narcolepsy with Cataplexy: Effects of Hypocretin Deficiency in HumansSLEEP, 2012
- Orexin A in rat rostral ventrolateral medulla is pressor, sympatho‐excitatory, increases barosensitivity and attenuates the somato‐sympathetic reflexBritish Journal of Pharmacology, 2011
- Sleep State SwitchingNeuron, 2010
- The orexin receptor 1 (OX1R) in the rostral medullary raphe contributes to the hypercapnic chemoreflex in wakefulness, during the active period of the diurnal cycleRespiratory Physiology & Neurobiology, 2010
- Antagonism of orexin receptor‐1 in the retrotrapezoid nucleus inhibits the ventilatory response to hypercapnia predominantly in wakefulnessThe Journal of Physiology, 2009
- Enhanced Orexin Receptor-2 Signaling Prevents Diet-Induced Obesity and Improves Leptin SensitivityCell Metabolism, 2009
- Control of hypothalamic orexin neurons by acid and CO 2Proceedings of the National Academy of Sciences, 2007